BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7192120)

  • 1. [Treatment of vertebrobasilar insufficiency with flunarizine (author's transl)].
    Hofferberth B
    Arzneimittelforschung; 1980; 30(10):1817-9. PubMed ID: 7192120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcium blockers in the therapy of vertebrobasilar insufficiency. Results of animal experiments and clinical studies].
    Hofferberth B
    Fortschr Med; 1984 Jul; 102(27-28):725-8. PubMed ID: 6383990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flunarizine and sulpiride--a comparison of 2 common antivertigo drugs in vertebrobasilar-induced vertigo].
    Hofferberth B; Grotemeyer KH
    Nervenarzt; 1985 Oct; 56(10):553-9. PubMed ID: 3906416
    [No Abstract]   [Full Text] [Related]  

  • 4. Vertigo, particularly of vascular origin, treated with flunarizine (R 14 950).
    Boniver R
    Acta Otorhinolaryngol Belg; 1979; 33(2):270-81. PubMed ID: 495086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of vertebrobasilar insufficiency. With flunarizine vertigo effectively controlled].
    Fortschr Med Suppl; 1985; 8():15-7. PubMed ID: 2867020
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
    Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
    Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of vertebrobasilar insufficiency--associated vertigo with a fixed combination of cinnarizine and dimenhydrinate.
    Otto V; Fischer B; Schwarz M; Baumann W; Preibisch-Effenberger R
    Int Tinnitus J; 2008; 14(1):57-67. PubMed ID: 18616088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of patients with vertigo of vertebrobasilar insufficiency origin using auditory brainstem response, electronystagmography, and transcranial Doppler.
    Mohamed ES; Kaf WA; Rageh TA; Kamel NF; Elattar AM
    Int J Audiol; 2012 May; 51(5):379-88. PubMed ID: 22299665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flunarizine in the treatment of vertigo.
    Wouters L; Amery W; Towse G
    J Laryngol Otol; 1983 Aug; 97(8):697-704. PubMed ID: 6350513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electronystagmography study in patients with the insufficiency of vertebrobasilar artery after betahistine treatment].
    Józefowicz-Korczyńska M; Lukomski M
    Neurol Neurochir Pol; 2000; 34(4):645-52. PubMed ID: 11105298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Managing vertebrobasilar insufficiency effectively. Flunarizine normalizes the incidence of nystagmus].
    Fortschr Med Suppl; 1986; 1():11-3. PubMed ID: 2868978
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of flunarizine on positional nystagmus].
    Petrone D; Riondino R; Fiorella R
    Boll Soc Ital Biol Sper; 1983 Jul; 59(7):903-8. PubMed ID: 6626332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double-blind clinical study: flunarizine versus pizotifen in a single nightly dose in hemicrania patients].
    Cerbo R; Casacchia M; Formisano R; Buzzi MG; Boni B; Feliciani M; Grillo G; Cusimano G; Agnoli A
    Riv Neurol; 1985; 55(2):139-46. PubMed ID: 4012191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flunarizine in the therapy of chronic cerebrovascular insufficiency. Multicentric controlled study].
    Arrigo A; Lottici P; Alfonsi E; Terraneo GB
    Clin Ter; 1984 Sep; 110(6):541-8. PubMed ID: 6238768
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with flunarizine in the treatment of otoneurologic symptoms].
    Materna F
    Med Welt; 1981 Jul; 32(29):1157-60. PubMed ID: 7266354
    [No Abstract]   [Full Text] [Related]  

  • 16. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
    Frenken CW; Nuijten ST
    Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
    Ambrosi V; Gabrielli F
    Minerva Med; 1983 Mar; 74(13):685-9. PubMed ID: 6220230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flunarizine in the treatment of arteriopathies of the legs].
    Catalano M; Sacchi E; Tomasini M; Coazzoli E; Parolini A; Dall'Oglio A; Libretti A
    Ric Clin Lab; 1985; 15 Suppl 1():475-8. PubMed ID: 4035228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists in the prevention of motion sickness.
    Lee JA; Watson LA; Boothby G
    Aviat Space Environ Med; 1986 Jan; 57(1):45-8. PubMed ID: 3510617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Movement disorders and depression due to flunarizine and cinnarizine.
    Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
    Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.